83,587 A shares of Orion Corporation converted into B shares
STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO STOCK EXCHANGE RULES
OCTOBER 26, 2022 at 10:00 a.m. EEST
83,587 Orion Corporation A shares converted into B shares
In accordance with Article 3 of the Orion Corporation Articles of Association, 83,587 A shares were converted into 83,587 B shares. The conversion was entered in the commercial register on October 26, 2022.
The total number of shares of Orion Corporation is 141,134,278 which after conversion consists of 34,226,937 A shares and 106,907,341 B shares. The number of votes of the shares of the company is after conversion 791,446 .081.
| Jari Karlson
| Olli Huotari
SVP, Corporate Functions
Tuukka Hirvonen, Investor Relations, tel. +358 10 426 2721
Orionintie 1A, FI-02200 Espoo, Finland
Orion is a globally operating Finnish pharmaceutical company – a wellness builder. Orion develops, manufactures and markets human and veterinary pharmaceutical products and active pharmaceutical ingredients. The company is constantly developing new drugs and treatment methods. The main therapeutic areas of Orion’s pharmaceutical R&D are oncology and pain. Orion’s net sales in 2021 were 1,041 million euros and the company had approximately 3,350 employees at the end of the year. Orion A and B shares are listed on Nasdaq Helsinki.